International Collaborative Study Reveals The Neuroprotective Properties of Phytocannabinoid Δ9-THCA

A recent Δ9-THCA (Δ9-tetrahydrocannabinol acid) study, initiated by three leading companies active in the field of medicinal cannabis research, has demonstrated its ability as a promising treatment modality for Huntington's disease (HD) and other metabolic, neurodegenerative and neuroinflammatory diseases.

SPAIN:  Advanced medical research conducted at Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) as a collaborative effort between Phytoplant Research SL, VivaCell Biotechnology España SL, and Emerald Health Pharmaceuticals has unveiled the potent neuroprotective ability of Δ9-THCA, a phytocannabinoid produced in Cannabis sativa L. The research paper was accepted and published in the British Journal of Pharmacology. Read the full article…

New Study Explores The Diversity of Phytocannabinoids of Different Botanical Origin

phytocannabinoids

An international team of leading researchers have paved the way to exploring the biomedical potential of phytocannabinoids, going beyond the THC structural motif and their occurrence in cannabis. SPAIN: In the first ever attempt to include phytocannabinoids from additional natural sources apart from those derived from C. sativa, the Hebrew University in Jerusalem, the University of Córdoba, Read the full article…

Japanese Study Shows Cannabinoids Inhibit Tumor Growth

JAPAN: In a recent study published in the August edition of the Journal of Pharmacy and Pharmacology, Japanese researchers found cannabinoids to be useful in battling cancerous tumors. The study was conducted by initiating tumor growth in mice and treating them with synthetic cannabinoids.

Japanese Study Shows Cannabinoids Inhibit Tumor Growth

Phytocannabinoids derived from Cannabis are typically more effective than Synthetic Cannabinoids in clinical trials for medical treatment.

JAPAN: In a recent study published in the August edition of the Journal of Pharmacy and Pharmacology, Japanese researchers found cannabinoids to be useful in battling cancerous tumors. The study was conducted by initiating tumor growth in mice and treating them with synthetic cannabinoids.